Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone for abstinence-induced cognitive symptoms in smokers
NCT01202955Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Tolcapone with Placebo (2 arms). Primary endpoint: Number of Eligible Participants Enrolled Who Completed the Study at 30 days. Started Jul 2008; status: completed.
02
Drugs
tolcapone
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01202955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202955.